Data from docking simulations to develop an efficient strategy able to evaluate the interactions between RAGE and...

Area of Science:

• Biochemistry
• Computational Biology
• Molecular Modeling

Background:

• Receptor for Advanced Glycation Endproducts (RAGE) plays a role in inflammatory diseases.
• Malondialdehyde (MDA)-induced adducts on human albumin can contribute to RAGE activation.
• Understanding RAGE-ligand interactions is crucial for disease mechanism elucidation.

Purpose of the Study:

• To develop and validate an in silico strategy for assessing the stability of RAGE-MDA-albumin complexes.
• To compare different computational approaches for modeling these interactions.
• To identify key albumin residues involved in RAGE recognition of modified sites.

Main Methods:

• Docking simulations were performed using various models of human albumin with MDA adducts.
• Models included tripeptides, pentapeptides, and spherical pseudo-structures of albumin residues around the adduct.
• The predictive accuracy of each model was evaluated by comparing docking scores of adducted versus unmodified residues.

Main Results:

• Spherical pseudo-structures demonstrated superior predictive power compared to tripeptide and pentapeptide models.
• Docking scores reliably differentiated between adducted and unmodified albumin residues using the pseudo-structure approach.
• RAGE recognition appears to involve residues spatially proximate to the modification, not solely adjacent ones.

Conclusions:

• In silico spherical pseudo-structures offer a robust method for predicting RAGE binding sites on modified albumin.
• This approach enhances understanding of RAGE-mediated pathways in diseases involving albumin adducts.
• The findings support the role of spatially close residues in RAGE-ligand complex stability.